Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127684321 | 12768432 | 1 | I | 20130503 | 20160913 | 20160921 | 20160921 | EXP | GB-MHRA-EYC 00144988 | GB-TAKEDA-2016TJP020316 | TAKEDA | 69.00 | YR | F | Y | 48.98000 | KG | 20160921 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127684321 | 12768432 | 1 | PS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | UNK | Y | 20406 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127684321 | 12768432 | 1 | Gastrooesophageal reflux disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127684321 | 12768432 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127684321 | 12768432 | Feeling cold | |
| 127684321 | 12768432 | Pain in extremity | |
| 127684321 | 12768432 | Peripheral coldness | |
| 127684321 | 12768432 | Peripheral swelling | |
| 127684321 | 12768432 | Poor peripheral circulation | |
| 127684321 | 12768432 | Skin discolouration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127684321 | 12768432 | 1 | 20130503 | 20160804 | 0 |